Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hoth Therapeutics Inc (HOTH)

Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hoth Therapeutics Inc 590 Madison Ave 21st Floor New York NY 10022 USA

https://hoththerapeutics.com Employees: 3 P: 646-756-2997

Description:

Hoth Therapeutics Inc. is a development stage biopharmaceutical company. It focused on therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. The company's BioLexa(TM) Platform is a proprietary, patented drug compound platform. Hoth Therapeutics Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 5,592
Enterprise Value, $K -3,698
Shares Outstanding, K 6,904
Annual Sales, $ 0 K
Annual Net Income, $ -7,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,130 K
EBIT, $ -7,560 K
EBITDA, $ -7,560 K
60-Month Beta 0.77
% of Insider Shareholders 10.56%
% of Institutional Shareholders 7.08%
Float, K 6,175
% Float 89.44%
Short Volume Ratio 0.58

Growth:

1-Year Return -30.77%
3-Year Return -95.61%
5-Year Return -99.44%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 81.60%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -1.32
EPS Growth vs. Prev Qtr -29.17%
EPS Growth vs. Prev Year 48.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/26/22

HOTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -89.68%
Return-on-Assets % -82.61%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.71
Book Value/Share 1.09
Interest Coverage -0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar